Wegovy 0.25 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FQ96E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,087
Award facts
- Contract value 100% obligated
- $16,086.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 13, 2025, for the supply of Wegovy 0.25 mg/0.5 mL pen injections with a contract ceiling value of $16,086.72. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 14, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that serves as the comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with the DLA and Defense Health Agency, supplying a comprehensive range of pharmaceutical products including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Wegovy, a GLP-1 receptor agonist used for weight management, aligns with the company's demonstrated capability to fulfill federal medical procurement requirements through open competition. The contract includes no set-aside designation, reflecting the company's ability to compete successfully in unrestricted federal procurement channels for pharmaceutical medical commodities supporting military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQ96E?
SPE2DR26FQ96E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FQ96E worth?
The government has obligated $16,087 on SPE2DR26FQ96E.
Is contract SPE2DR26FQ96E an order under another contract?
Yes. SPE2DR26FQ96E is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FQ96E competed?
The extent of competition for SPE2DR26FQ96E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award